In haematological malignancies, high expression of NRF2 has been found in patients of acute myeloid leukaemia (AML) [23,24,25], chronic lymphocytic leukaemia (CLL) [26] and acute lymphoblastic leukaemia (ALL) [7,27]. Here, NFE2L2 is linked to acute myeloid leukemia.